Open Access
Leishmaniasis
Publication type: Journal Article
Publication date: 2018-09-01
scimago Q1
wos Q1
SJR: 12.113
CiteScore: 87.6
Impact factor: 88.5
ISSN: 01406736, 1474547X
PubMed ID:
30126638
General Medicine
Abstract
Leishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0·7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
10
20
30
40
50
60
70
|
|
|
PLoS Neglected Tropical Diseases
70 publications, 4.42%
|
|
|
Frontiers in Cellular and Infection Microbiology
44 publications, 2.78%
|
|
|
Acta Tropica
37 publications, 2.34%
|
|
|
Pathogens
36 publications, 2.27%
|
|
|
Parasites and Vectors
34 publications, 2.15%
|
|
|
Frontiers in Immunology
33 publications, 2.08%
|
|
|
Tropical Medicine and Infectious Disease
27 publications, 1.7%
|
|
|
Molecules
26 publications, 1.64%
|
|
|
Microorganisms
25 publications, 1.58%
|
|
|
European Journal of Medicinal Chemistry
22 publications, 1.39%
|
|
|
ACS Infectious Diseases
21 publications, 1.33%
|
|
|
Scientific Reports
20 publications, 1.26%
|
|
|
Pharmaceutics
16 publications, 1.01%
|
|
|
PLoS ONE
15 publications, 0.95%
|
|
|
Pharmaceuticals
14 publications, 0.88%
|
|
|
Parasitology Research
14 publications, 0.88%
|
|
|
International Journal of Molecular Sciences
13 publications, 0.82%
|
|
|
Experimental Parasitology
13 publications, 0.82%
|
|
|
International Journal for Parasitology: Drugs and Drug Resistance
12 publications, 0.76%
|
|
|
Vaccines
10 publications, 0.63%
|
|
|
PLoS Pathogens
10 publications, 0.63%
|
|
|
BMC Infectious Diseases
9 publications, 0.57%
|
|
|
Acta Parasitologica
9 publications, 0.57%
|
|
|
Microbiology spectrum
9 publications, 0.57%
|
|
|
Parasite Immunology
9 publications, 0.57%
|
|
|
Transactions of the Royal Society of Tropical Medicine and Hygiene
9 publications, 0.57%
|
|
|
American Journal of Tropical Medicine and Hygiene
8 publications, 0.51%
|
|
|
Microbial Pathogenesis
8 publications, 0.51%
|
|
|
Cytokine
8 publications, 0.51%
|
|
|
10
20
30
40
50
60
70
|
Publishers
|
50
100
150
200
250
300
350
400
|
|
|
Elsevier
380 publications, 23.99%
|
|
|
MDPI
233 publications, 14.71%
|
|
|
Springer Nature
204 publications, 12.88%
|
|
|
Frontiers Media S.A.
110 publications, 6.94%
|
|
|
Public Library of Science (PLoS)
97 publications, 6.12%
|
|
|
Wiley
84 publications, 5.3%
|
|
|
Cold Spring Harbor Laboratory
71 publications, 4.48%
|
|
|
American Chemical Society (ACS)
53 publications, 3.35%
|
|
|
Oxford University Press
45 publications, 2.84%
|
|
|
American Society for Microbiology
41 publications, 2.59%
|
|
|
Taylor & Francis
38 publications, 2.4%
|
|
|
Royal Society of Chemistry (RSC)
14 publications, 0.88%
|
|
|
Bentham Science Publishers Ltd.
12 publications, 0.76%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
12 publications, 0.76%
|
|
|
SciELO
9 publications, 0.57%
|
|
|
IntechOpen
9 publications, 0.57%
|
|
|
American Society of Tropical Medicine and Hygiene
8 publications, 0.51%
|
|
|
Cambridge University Press
8 publications, 0.51%
|
|
|
Hindawi Limited
8 publications, 0.51%
|
|
|
F1000 Research
6 publications, 0.38%
|
|
|
SAGE
6 publications, 0.38%
|
|
|
BMJ
6 publications, 0.38%
|
|
|
Centers for Disease Control and Prevention (CDC)
5 publications, 0.32%
|
|
|
EDP Sciences
5 publications, 0.32%
|
|
|
Mary Ann Liebert
4 publications, 0.25%
|
|
|
Walter de Gruyter
4 publications, 0.25%
|
|
|
Medknow
4 publications, 0.25%
|
|
|
Fundacao Oswaldo Cruz
4 publications, 0.25%
|
|
|
Sociedade Brasileira de Medicina Tropical
4 publications, 0.25%
|
|
|
50
100
150
200
250
300
350
400
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.6k
Total citations:
1586
Citations from 2024:
466
(29.42%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S0140-6736(18)31204-2
UR - https://doi.org/10.1016/S0140-6736(18)31204-2
TI - Leishmaniasis
T2 - The Lancet
AU - Burza, Sakib
AU - Croft, Simon L.
AU - Boelaert, Marleen
PY - 2018
DA - 2018/09/01
PB - Elsevier
SP - 951-970
IS - 10151
VL - 392
PMID - 30126638
SN - 0140-6736
SN - 1474-547X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Burza,
author = {Sakib Burza and Simon L. Croft and Marleen Boelaert},
title = {Leishmaniasis},
journal = {The Lancet},
year = {2018},
volume = {392},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016/S0140-6736(18)31204-2},
number = {10151},
pages = {951--970},
doi = {10.1016/S0140-6736(18)31204-2}
}
Cite this
MLA
Copy
Burza, Sakib, et al. “Leishmaniasis.” The Lancet, vol. 392, no. 10151, Sep. 2018, pp. 951-970. https://doi.org/10.1016/S0140-6736(18)31204-2.